海正藥業(600267.SH):海正南通公司非潑羅尼原料藥獲得CEP證書
格隆匯11月27日丨海正藥業(600267.SH)公佈,近日,公司全資子公司海正藥業南通有限公司(簡稱“海正南通公司”)收到歐洲藥品質量管理局(European Directorate for the Quality of Medicines & Health Care,以下簡稱“EDQM”)簽發的非潑羅尼原料藥歐洲藥典適用性認證證書(Certificate of Suitability to Monograph of European Pharmacopoeia,以下簡稱“CEP證書”)。
非潑羅尼是一種苯基吡唑類殺蟲劑、殺蟲譜廣,對害蟲以胃毒作用為主,兼有觸殺和一定的內吸作用,其作用機制在於阻礙昆蟲γ-氨基丁酸控制的氯化物代謝,因此對蚜蟲、葉蟬、飛蝨、鱗翅目幼蟲、蠅類和鞘翅目等重要害蟲有很高的殺蟲活性,對作物無藥害。該藥劑可施於土壤,也可葉面噴霧。目前,國內非潑羅尼原料藥的主要生產、銷售廠商有海正藥業南通有限公司、山東阿維化工有限公司等。公司未能從公開渠道查詢到非潑羅尼原料藥的全球銷售額數據。
海正南通公司於2018年7月6日向EDQM提交了非潑羅尼原料藥的CEP申請,公司在該藥品研發項目上已投入約713.67萬元人民幣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.